Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.2B | 15.2B | 14.2B | 15.7B |
Cost of revenue | 11.1B | 12.5B | 11.3B | 12.1B |
Gross profit | 3.1B | 2.7B | 2.9B | 3.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 197M | 201M | 172M | 175M |
Other operating expenses | 1.6B | 1.7B | 1.7B | 1.9B |
Operating income | 1.3B | 841M | 1.0B | 1.5B |
Non operating interest income | ||||
Income | 33M | 47M | 51M | 37M |
Expense | 163M | 162M | 160M | 163M |
Other income expense | -18M | -537M | 108M | -50M |
Pretax income | 1.1B | 184M | 1.0B | 1.3B |
Tax provision | 271M | 38M | 204M | 309M |
Net income | 859M | 146M | 820M | 1B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 2.6B | 2.0B | 2.3B | 2.8B |
Net income from continuing op. | 859M | 146M | 820M | 1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |